162 related articles for article (PubMed ID: 31377298)
1. Synthesis of pectin-deoxycholic acid conjugate for targeted delivery of anticancer drugs in hepatocellular carcinoma.
Varshosaz J; Sadri F; Rostami M; Mirian M; Taymouri S
Int J Biol Macromol; 2019 Oct; 139():665-677. PubMed ID: 31377298
[TBL] [Abstract][Full Text] [Related]
2. Apolipoprotein E Peptide-Guided Disulfide-Cross-Linked Micelles for Targeted Delivery of Sorafenib to Hepatocellular Carcinoma.
Li Y; Wei J; Wei Y; Cheng L; Guo B; Meng F; Li F; Zhong Z
Biomacromolecules; 2020 Feb; 21(2):716-724. PubMed ID: 31809037
[TBL] [Abstract][Full Text] [Related]
3. Targeted therapy for human hepatic carcinoma cells using folate-functionalized polymeric micelles loaded with superparamagnetic iron oxide and sorafenib in vitro.
Zhang L; Gong F; Zhang F; Ma J; Zhang P; Shen J
Int J Nanomedicine; 2013; 8():1517-24. PubMed ID: 23620667
[TBL] [Abstract][Full Text] [Related]
4. Amphiphilic Polymeric Micelles Based on Deoxycholic Acid and Folic Acid Modified Chitosan for the Delivery of Paclitaxel.
Li L; Liang N; Wang D; Yan P; Kawashima Y; Cui F; Sun S
Int J Mol Sci; 2018 Oct; 19(10):. PubMed ID: 30322014
[TBL] [Abstract][Full Text] [Related]
5. Engineering of pectin-capped gold nanoparticles for delivery of doxorubicin to hepatocarcinoma cells: an insight into mechanism of cellular uptake.
Borker S; Pokharkar V
Artif Cells Nanomed Biotechnol; 2018; 46(sup2):826-835. PubMed ID: 29749275
[TBL] [Abstract][Full Text] [Related]
6. Lactobionic/Folate Dual-Targeted Amphiphilic Maltodextrin-Based Micelles for Targeted Codelivery of Sulfasalazine and Resveratrol to Hepatocellular Carcinoma.
Anwar DM; Khattab SN; Helmy MW; Kamal MK; Bekhit AA; Elkhodairy KA; Elzoghby AO
Bioconjug Chem; 2018 Sep; 29(9):3026-3041. PubMed ID: 30110148
[TBL] [Abstract][Full Text] [Related]
7. Sorafenib-loaded polymeric micelles as passive targeting therapeutic agents for hepatocellular carcinoma therapy.
Su Y; Wang K; Li Y; Song W; Xin Y; Zhao W; Tian J; Ren L; Lu L
Nanomedicine (Lond); 2018 May; 13(9):1009-1023. PubMed ID: 29630448
[TBL] [Abstract][Full Text] [Related]
8. Ligand-directed reduction-sensitive shell-sheddable biodegradable micelles actively deliver doxorubicin into the nuclei of target cancer cells.
Zhong Y; Yang W; Sun H; Cheng R; Meng F; Deng C; Zhong Z
Biomacromolecules; 2013 Oct; 14(10):3723-30. PubMed ID: 23998942
[TBL] [Abstract][Full Text] [Related]
9. Biological evaluation of redox-sensitive micelles based on hyaluronic acid-deoxycholic acid conjugates for tumor-specific delivery of paclitaxel.
Li J; Yin T; Wang L; Yin L; Zhou J; Huo M
Int J Pharm; 2015 Apr; 483(1-2):38-48. PubMed ID: 25655715
[TBL] [Abstract][Full Text] [Related]
10. PEGylated trimethylchitosan emulsomes conjugated to octreotide for targeted delivery of sorafenib to hepatocellular carcinoma cells of HepG2.
Varshosaz J; Raghami F; Rostami M; Jahanian A
J Liposome Res; 2019 Dec; 29(4):383-398. PubMed ID: 30668221
[TBL] [Abstract][Full Text] [Related]
11. PDA-Based Glyconanomicelles for Hepatocellular Carcinoma Cells Active Targeting Via Mannose and Asialoglycoprotein Receptors.
Negrete M; Romero-Ben E; Gutiérrez-Valencia A; Rosales-Barrios C; Alés E; Mena-Barragán T; Flores JA; Castillejos MC; de la Cruz-Ojeda P; Navarro-Villarán E; Cepeda-Franco C; Khiar N; Muntané J
ACS Appl Bio Mater; 2021 Jun; 4(6):4789-4799. PubMed ID: 35007028
[TBL] [Abstract][Full Text] [Related]
12. Galactosylated nanostructured lipid carriers for delivery of 5-FU to hepatocellular carcinoma.
Varshosaz J; Hassanzadeh F; Sadeghi H; Khadem M
J Liposome Res; 2012 Sep; 22(3):224-36. PubMed ID: 22385296
[TBL] [Abstract][Full Text] [Related]
13. Ceramide-Fabricated Co-Loaded Liposomes for the Synergistic Treatment of Hepatocellular Carcinoma.
Yin X; Xiao Y; Han L; Zhang B; Wang T; Su Z; Zhang N
AAPS PharmSciTech; 2018 Jul; 19(5):2133-2143. PubMed ID: 29714002
[TBL] [Abstract][Full Text] [Related]
14. Angelica sinensis polysaccharide nanoparticles as a targeted drug delivery system for enhanced therapy of liver cancer.
Zhang Y; Cui Z; Mei H; Xu J; Zhou T; Cheng F; Wang K
Carbohydr Polym; 2019 Sep; 219():143-154. PubMed ID: 31151511
[TBL] [Abstract][Full Text] [Related]
15. Asialoglycoprotein receptor targeted micelles containing carborane clusters for effective boron neutron capture therapy of hepatocellular carcinoma.
Zhang T; Li G; Li S; Wang Z; He D; Wang Y; Zhang J; Li J; Bai Z; Zhang Q; Liu B; Zhao Q; Liu Y; Zhang H
Colloids Surf B Biointerfaces; 2019 Oct; 182():110397. PubMed ID: 31357127
[TBL] [Abstract][Full Text] [Related]
16. Targeted and synergistic therapy for hepatocellular carcinoma: monosaccharide modified lipid nanoparticles for the co-delivery of doxorubicin and sorafenib.
Duan W; Liu Y
Drug Des Devel Ther; 2018; 12():2149-2161. PubMed ID: 30034219
[TBL] [Abstract][Full Text] [Related]
17. Sorafenib-Loaded Nanoparticles Based on Biodegradable Dendritic Polymers for Enhanced Therapy of Hepatocellular Carcinoma.
Li Z; Ye L; Liu J; Lian D; Li X
Int J Nanomedicine; 2020; 15():1469-1480. PubMed ID: 32184599
[TBL] [Abstract][Full Text] [Related]
18. Redox-sensitive micelles self-assembled from amphiphilic hyaluronic acid-deoxycholic acid conjugates for targeted intracellular delivery of paclitaxel.
Li J; Huo M; Wang J; Zhou J; Mohammad JM; Zhang Y; Zhu Q; Waddad AY; Zhang Q
Biomaterials; 2012 Mar; 33(7):2310-20. PubMed ID: 22166223
[TBL] [Abstract][Full Text] [Related]
19.
Sun R; Fang L; Lv X; Fang J; Wang Y; Chen D; Wang L; Chen J; Qi Y; Tang Z; Zhang J; Tian Y
Drug Deliv; 2021 Dec; 28(1):2071-2084. PubMed ID: 34595970
[TBL] [Abstract][Full Text] [Related]
20. Targeted Therapy for Hepatocellular Carcinoma: Co-Delivery of Sorafenib and Curcumin Using Lactosylated pH-Responsive Nanoparticles.
Bian Y; Guo D
Drug Des Devel Ther; 2020; 14():647-659. PubMed ID: 32109990
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
